ND
ENDRA Life Sciences Inc.
NDRA · NASDAQ
$5.91 -0.42% (-$0.02)
1M +33.11%
Market Cap $7.50M
P/E Ratio -
Div. Yield -
ROE 224.80%
Bulios Fair Price
$5.87
0.6% downside
Current Price
$5.91
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NDRA is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.19x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 32.05%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 91.16%
ROE 224.80%
ROA 74.50%
Debt
100 /100
Low Debt/Equity 0.07x
Current ratio 7.10x
Int. coverage N/A
Stability
35 /100
Moderate Beta -0.07x
EPS volatility 50.47%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NDRA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Alexander Y. Tokman
Employees
10
Headquarters
Ann Arbor
Upcoming events
13 NOV
Earnings
Upcoming earnings report